Stay updated with breaking news from Kodiak Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Connor Clark & Lunn Investment Management Ltd. boosted its holdings in shares of Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) by 195.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,715 shares of the company’s stock after buying an additional 55,409 shares […]
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...
/PRNewswire/ -- The "Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly...
Martingale Asset Management L P purchased a new position in shares of Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) in the second quarter, Holdings Channel.com reports. The firm purchased 13,387 shares of the company’s stock, valued at approximately $103,000. Other institutional investors also recently bought and sold shares of the company. Mirae Asset Global Investments […]
/PRNewswire/ -- Kodiak Sciences Inc. (NASDAQ: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...